1. Home
  2. GVH vs TOVX Comparison

GVH vs TOVX Comparison

Compare GVH & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GVH
  • TOVX
  • Stock Information
  • Founded
  • GVH 2016
  • TOVX 2001
  • Country
  • GVH Australia
  • TOVX United States
  • Employees
  • GVH N/A
  • TOVX N/A
  • Industry
  • GVH
  • TOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GVH
  • TOVX Health Care
  • Exchange
  • GVH Nasdaq
  • TOVX Nasdaq
  • Market Cap
  • GVH N/A
  • TOVX 3.5M
  • IPO Year
  • GVH 2023
  • TOVX 2006
  • Fundamental
  • Price
  • GVH $0.64
  • TOVX $1.14
  • Analyst Decision
  • GVH
  • TOVX Strong Buy
  • Analyst Count
  • GVH 0
  • TOVX 1
  • Target Price
  • GVH N/A
  • TOVX $6.00
  • AVG Volume (30 Days)
  • GVH 22.3K
  • TOVX 96.3K
  • Earning Date
  • GVH 02-15-2025
  • TOVX 11-12-2024
  • Dividend Yield
  • GVH N/A
  • TOVX N/A
  • EPS Growth
  • GVH 67.24
  • TOVX N/A
  • EPS
  • GVH 0.11
  • TOVX N/A
  • Revenue
  • GVH $17,570,748.00
  • TOVX N/A
  • Revenue This Year
  • GVH N/A
  • TOVX N/A
  • Revenue Next Year
  • GVH N/A
  • TOVX N/A
  • P/E Ratio
  • GVH $5.93
  • TOVX N/A
  • Revenue Growth
  • GVH N/A
  • TOVX N/A
  • 52 Week Low
  • GVH $0.47
  • TOVX $1.14
  • 52 Week High
  • GVH $2.57
  • TOVX $17.00
  • Technical
  • Relative Strength Index (RSI)
  • GVH 38.16
  • TOVX 36.15
  • Support Level
  • GVH $0.66
  • TOVX $1.23
  • Resistance Level
  • GVH $0.69
  • TOVX $1.21
  • Average True Range (ATR)
  • GVH 0.04
  • TOVX 0.07
  • MACD
  • GVH -0.00
  • TOVX 0.01
  • Stochastic Oscillator
  • GVH 0.00
  • TOVX 0.00

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: